Keyword: GlaxoSmithKline (GSK)
News
21.01.2015
- GlaxoSmithKline could consider more partial public share offerings for component units as it evolves in the coming years, potentially pointing to a break-up of the group if this...
News
01.12.2014
- Merck KGaA has no plans to divest its consumer health business, but rather intends to expand it, Uta Kemmerich-Keil, CEO of Merck Consumer Health, said at a media briefing in...
News
27.10.2014
- GlaxoSmithKline (GSK), the UK's largest pharmaceutical producer, said development of the company's experimental Ebola vaccine candidate is progressing "at an unprecedented rate,"...
News
06.10.2014
- The US government is stepping up production of ZMapp, believed to be one the most promising of the Ebola drugs currently under development. The Department of Health and Human...
News
06.10.2014
- Bayer has closed its $14.2 billion acquisition of US Merck & Co's $2.2 billion consumer care business after the transaction was approved by anti-trust authorities in all markets...
Markets & Companies
02.10.2014
- Recently, Codexis has signed a platform technology license agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Codexis, a developer of biocatalysts for the...
News
23.09.2014
- GlaxoSmithkline (GSK), the UK's largest pharmaceutical producer, will pay the Chinese government nearly $500 million in fines after being found guilty of offering bribes to...
Markets & Companies
02.09.2014
- The first half suggests that 2014 will be a record year for M&A in pharmaceuticals, with the size of deals having increased substantially over prior years. In 2011, the deal volume...
